News: Research

Protein large language models identify ways to make antibiotics better at targeting dangerous bacteria, without being toxic to humans.

An innovative approach uses artificial intelligence and biosensors to pave the way for faster drug development.

Yi Lu and Lauren Ehrlich of the College of Natural Sciences are among the cancer researchers with exciting projects on the horizon.

The discovery could lead to better treatments for acute myeloid leukemia in vulnerable populations.

Bacteria use iron levels to store memories and pass them on to later generations, scientists have found.

A team led by Lauren Ehrlich found a link between myeloid cells and the cancer that often strikes children.

Drug candidate developed by Everett Stone and his team is effective in mice with cancers of skin, bladder, blood and colon.

Kyle Miller and his team discovered a potential new target for drug therapies: structures in our DNA called R-loops.

The earliest stages of developing life have been, in many ways, a black box for researchers before now.

Alone, this target might not be strong enough to directly block infection, but might be used to jump-start or boost an immune response.